ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 120 filers reported holding ENZO BIOCHEM INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $264,000 | -33.5% | 32,342 | -14.7% | 0.20% | -39.3% |
Q3 2017 | $397,000 | +7.3% | 37,933 | +13.2% | 0.32% | -6.7% |
Q2 2017 | $370,000 | +208.3% | 33,513 | +133.9% | 0.34% | +10.6% |
Q1 2017 | $120,000 | +50.0% | 14,325 | +24.4% | 0.31% | +25.9% |
Q4 2016 | $80,000 | – | 11,513 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Roumell Asset Management, LLC | 2,886,771 | $10,219,000 | 13.54% |
HARBERT FUND ADVISORS, INC. | 5,175,913 | $18,323,000 | 6.51% |
Evermore Global Advisors, LLC | 1,730,607 | $6,126,000 | 5.39% |
VIEX Capital Advisors, LLC | 1,510,401 | $5,347,000 | 3.24% |
KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $90,000 | 0.05% |
RBF Capital, LLC | 250,359 | $886,000 | 0.05% |
CORRADO ADVISORS, LLC | 19,366 | $69,000 | 0.04% |
Cutter & CO Brokerage, Inc. | 27,827 | $99,000 | 0.02% |
Ergoteles LLC | 177,048 | $627,000 | 0.02% |
FULLER & THALER ASSET MANAGEMENT, INC. | 941,760 | $3,334,000 | 0.02% |